Triple

T4210285
Position Surface form Disambiguated ID Type / Status
Subject Office of Rare Diseases Research E93883 entity
Predicate supportsProgram P178 FINISHED
Object Rare Diseases Clinical Research Network
The Rare Diseases Clinical Research Network is a collaborative NIH-funded consortium that conducts clinical studies, develops diagnostics and treatments, and advances knowledge for patients affected by rare diseases.
E421896 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rare Diseases Clinical Research Network | Statement: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Clinical Research Network]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Rare Diseases Clinical Research Network
Context triple: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Clinical Research Network]
  • A. Office of Rare Diseases Research
    The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
  • B. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • C. Cystic Fibrosis Research Center
    The Cystic Fibrosis Research Center is a specialized research facility at the UNC School of Medicine focused on advancing understanding and treatment of cystic fibrosis through basic, translational, and clinical studies.
  • D. The Jackson Laboratory for Genomic Medicine
    The Jackson Laboratory for Genomic Medicine is a biomedical research institute specializing in genomics and precision medicine, focusing on understanding the genetic basis of disease to advance diagnostics and therapies.
  • E. National Institute of Arthritis and Musculoskeletal and Skin Diseases
    The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Rare Diseases Clinical Research Network
Triple: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Clinical Research Network]
Generated description
The Rare Diseases Clinical Research Network is a collaborative NIH-funded consortium that conducts clinical studies, develops diagnostics and treatments, and advances knowledge for patients affected by rare diseases.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Rare Diseases Clinical Research Network
Target entity description: The Rare Diseases Clinical Research Network is a collaborative NIH-funded consortium that conducts clinical studies, develops diagnostics and treatments, and advances knowledge for patients affected by rare diseases.
  • A. Office of Rare Diseases Research
    The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
  • B. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • C. Cystic Fibrosis Research Center
    The Cystic Fibrosis Research Center is a specialized research facility at the UNC School of Medicine focused on advancing understanding and treatment of cystic fibrosis through basic, translational, and clinical studies.
  • D. The Jackson Laboratory for Genomic Medicine
    The Jackson Laboratory for Genomic Medicine is a biomedical research institute specializing in genomics and precision medicine, focusing on understanding the genetic basis of disease to advance diagnostics and therapies.
  • E. National Institute of Arthritis and Musculoskeletal and Skin Diseases
    The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451743608190808f41d17ccf2650 completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34810de648190b09c5e705cf0a74e completed March 12, 2026, 11:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69b5962ec4f8819085bef81ce71aa132 completed March 14, 2026, 5:09 p.m.
NEDg Description generation batch_69b596eb6c288190a63c61d5e71c609b completed March 14, 2026, 5:12 p.m.
NED2 Entity disambiguation (via description) batch_69b59788ef308190a34c2f23f22a7e4d completed March 14, 2026, 5:14 p.m.
Created at: March 12, 2026, 11:03 p.m.